Business Wire - Salix Initiates Phase 3 For Rifaximin in Non-Constipation Irritable Bowel Syndrome
June 30, 2008 -- IBS Affects Approximately 15% of U.S. Population IBS U.S. Market Opportunity Exceeds $2 Billion RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd....
Market Wire - A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Launches Breze(TM) Pads for the Topical Treatment of Acne Vulgaris
April 1, 2008 -- Auriga Laboratories, Inc. (OTCBB: ARGA), aspecialty pharmaceutical company today announced the launch of Breze(TM)Pads (benzoyl peroxide 4.75% and...
Photochemistry and Photobiology - Comparable Photoreactivity of Hair Melanosomes, Eu- and Pheomelanins at Low Concentrations: Low Melanin a Risk Factor for UVA Damage and Melanoma?[dagger]
May 1, 2008 -- ABSTRACT Melanin is known to be photoreactive and photoprotective, but its function in skin in vivo is still debated. Data is lacking of the effects...
Business Wire - Salix Pharmaceuticals to Present at BMO Capital Markets Conference
November 27, 2007 -- RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the BMO Capital Markets Focus on...
Business Wire - Salix Pharmaceuticals to Present at Piper Jaffray Health Care Conference
November 21, 2007 -- RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 19th Annual Piper Jaffray Health Care...
Asian - Australasian Journal of Animal Sciences - Fleece phenotype influences susceptibility to cortisol-induced follicle shutdown in merino sheep
November 1, 2007 -- ABSTRACT : This experiment was conducted to determine the extent to which susceptibility to cortisol-induced follicle shutdown is influenced by...
Business Wire - CollaGenex Pharmaceuticals to Present at the RBC Capital Markets' Healthcare Conference on December 12th
December 5, 2007 -- NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will...
Business Wire - CollaGenex Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference on December 4th
November 27, 2007 -- NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will...
Business Wire - Salix Pharmaceuticals Announces 3Q2007 Financial Results Conference Call and Webcast
October 23, 2007 -- RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report third quarter ended September 30, 2007...
Business Wire - CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets 4th Annual Healthcare Conference on November 27th
November 20, 2007 -- NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will...
